Pharma Stocks
Outlook for the week - 10 to 14.11.2014
( www.rupeedesk.in )
Stocks of frontline pharmaceutical
companies are seen trading positive next week on defensive buying, as well as the
momentum in some stocks from their good Jul-Sep earnings.
Some consolidation is expected in the
broader markets due to profit booking in some key sectors and based on that we'll
see buying in defensive sectors like pharma.
Stocks of Dr Reddy's Laboratories and
Sun Pharma to outperform peers in the sector, while those of Cipla are seen trading
sideways, and thus being the underperformers in the sector.
The Street expects the shares of
Aurobindo Pharma to rise going ahead based on its Jul-Sep results. The company reported
a net profit for the quarter at 4.1 bln rupees, and revenues at 28.8 bln rupees.
